Search

Search results

Current filters: Hepatitis C drugs, Treatment, Research summary

40 search results

Safety and efficacy of glecaprevir + pibrentasvir (Maviret) in cases of liver or kidney transplant with chronic HCV infection

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Glecaprevir + pibrentasvir (Maviret) in HCV genotype 1 or 4 with previous treatment failure

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Know your drugs and classes of HCV treatment

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Better blood sugar control in people with diabetes after HCV has been cured

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Improvements in mood and energy after successful HCV treatments

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

New treatments for hepatitis C virus (HCV) to get approved in Canada later this year

From TreatmentUpdate 221
2017, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir – improvements in quality of life, energy and emotional and mental health

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir – interactions with other medicines

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir in HIV co-infection

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage

Sofosbuvir + velpatasvir (Epclusa) + ribavirin for retreatment

From TreatmentUpdate 216
2016, CATIE
Research summary - Webpage